CV Sciences annual gross margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
CV Sciences's gross margin was 48.97% for fiscal 2025.
View full CV Sciences company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 48.97% | +3.33 pp |
| 2024 | 2024-12-31 | 45.64% | +1.37 pp |
| 2023 | 2023-12-31 | 44.27% | +10.02 pp |
| 2022 | 2022-12-31 | 34.25% | −8.73 pp |
| 2021 | 2021-12-31 | 42.98% | −2.09 pp |
| 2020 | 2020-12-31 | 45.07% | −20.28 pp |
| 2019 | 2019-12-31 | 65.35% | −4.88 pp |
| 2018 | 2018-12-31 | 70.22% | +0.16 pp |
| 2017 | 2017-12-31 | 70.07% | +6.80 pp |
| 2016 | 2016-12-31 | 63.27% | +4.89 pp |
| 2015 | 2015-12-31 | 58.38% | +1.43 pp |
| 2014 | 2014-12-31 | 56.95% | −2.17 pp |
| 2013 | 2013-12-31 | 59.13% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 48.58% | −2.36 pp |
| Q1 2026 | 2026-03-31 | 48.89% | +2.91 pp |
| Q4 2025 | 2025-12-31 | 50.53% | +7.35 pp |
| Q3 2025 | 2025-09-30 | 48.50% | +2.49 pp |
| Q2 2025 | 2025-06-30 | 50.94% | +3.90 pp |
| Q1 2025 | 2025-03-31 | 45.98% | −0.32 pp |
| Q4 2024 | 2024-12-31 | 43.18% | −2.65 pp |
| Q3 2024 | 2024-09-30 | 46.00% | +0.93 pp |
| Q2 2024 | 2024-06-30 | 47.04% | +3.72 pp |
| Q1 2024 | 2024-03-31 | 46.30% | +3.34 pp |
| Q4 2023 | 2023-12-31 | 45.83% | +5.46 pp |
| Q3 2023 | 2023-09-30 | 45.07% | +3.43 pp |
| Q2 2023 | 2023-06-30 | 43.32% | +12.63 pp |
| Q1 2023 | 2023-03-31 | 42.96% | +16.97 pp |
| Q4 2022 | 2022-12-31 | 40.37% | +7.97 pp |
| Q3 2022 | 2022-09-30 | 41.64% | −4.53 pp |
| Q2 2022 | 2022-06-30 | 30.69% | −13.97 pp |
| Q1 2022 | 2022-03-31 | 26.00% | −22.68 pp |
| Q4 2021 | 2021-12-31 | 32.40% | −10.32 pp |
| Q3 2021 | 2021-09-30 | 46.17% | +2.00 pp |
| Q2 2021 | 2021-06-30 | 44.66% | +1.62 pp |
| Q1 2021 | 2021-03-31 | 48.68% | +0.21 pp |
| Q4 2020 | 2020-12-31 | 42.72% | −1.77 pp |
| Q3 2020 | 2020-09-30 | 44.18% | −22.70 pp |
| Q2 2020 | 2020-06-30 | 43.03% | −27.88 pp |
| Q1 2020 | 2020-03-31 | 48.46% | −22.35 pp |
| Q4 2019 | 2019-12-31 | 44.49% | −20.97 pp |
| Q3 2019 | 2019-09-30 | 66.87% | −6.25 pp |
| Q2 2019 | 2019-06-30 | 70.91% | −2.46 pp |
| Q1 2019 | 2019-03-31 | 70.81% | +1.90 pp |
| Q4 2018 | 2018-12-31 | 65.46% | −6.54 pp |
| Q3 2018 | 2018-09-30 | 73.13% | +1.63 pp |
| Q2 2018 | 2018-06-30 | 73.37% | +3.68 pp |
| Q1 2018 | 2018-03-31 | 68.91% | +4.28 pp |
| Q4 2017 | 2017-12-31 | 72.00% | +15.34 pp |
| Q3 2017 | 2017-09-30 | 71.50% | +7.25 pp |
| Q2 2017 | 2017-06-30 | 69.69% | +2.79 pp |
| Q1 2017 | 2017-03-31 | 64.64% | −2.47 pp |
| Q4 2016 | 2016-12-31 | 56.65% | −5.83 pp |
| Q3 2016 | 2016-09-30 | 64.25% | +5.02 pp |
| Q2 2016 | 2016-06-30 | 66.90% | +13.54 pp |
| Q1 2016 | 2016-03-31 | 67.10% | +8.96 pp |
| Q4 2015 | 2015-12-31 | 62.49% | +15.16 pp |
| Q3 2015 | 2015-09-30 | 59.23% | −1.12 pp |
| Q2 2015 | 2015-06-30 | 53.36% | −6.38 pp |
| Q1 2015 | 2015-03-31 | 58.14% | −3.07 pp |
| Q4 2014 | 2014-12-31 | 47.33% | +23.57 pp |
| Q3 2014 | 2014-09-30 | 60.35% | −9.99 pp |
| Q2 2014 | 2014-06-30 | 59.75% | −25.13 pp |
| Q1 2014 | 2014-03-31 | 61.21% | −19.81 pp |
| Q4 2013 | 2013-12-31 | 23.76% | — |
| Q3 2013 | 2013-09-30 | 70.33% | — |
| Q2 2013 | 2013-06-30 | 84.87% | — |
| Q1 2013 | 2013-03-31 | 81.02% | — |
Over the last five reported fiscal years, CV Sciences's gross margin increased from 45.07% to 48.97%, a change of +3.90 percentage points. The latest reported quarter, Q2 2026, shows 48.58%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CV Sciences filings at SEC.gov ↗